Skip to content
DataLookout
Menu

NCT04167631

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
  2. Notable Primary completion date: Dec 1, 2023 to Dec 1, 2024
    • Study completion date: Jan 1, 2024 to Dec 2024
    v5
  3. Notable Primary completion date: Jun 1, 2020 to Dec 1, 2023
    • Study completion date: Jun 1, 2020 to Jan 1, 2024
    v4
  4. Minor Study title shortened, about 3 wordsv3
  5. Minor Study description expanded, about 75 words
    • Study title shortened, about 10 words
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Vesical Imaging-Reporting And Data System (VI-RADS) for discriminating muscle invasive bladder cancer (MIBC) from non-muscle invasive bladder cancer (NMIBC) using multi-parametric MRI.
Timeframe: 18 months

Arms and interventions

Multiparametric MRIOther

Vesical Imaging-Reporting And Data System (VI-RADS) using multi-parametric MRI.

Radiation: Multi-parametric MRI

Sites

1 site in 1 country

  • Urology and Nephrology CenterAl Mansurah, Aldakahlia, Egypt